Tuesday, December 29, 2015 9:15:05 AM
Recent AMGN News
- Amgen, Bock Up; Cloudflare, Expedia Weak • IH Market News • 05/03/2024 01:12:08 PM
- AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS • PR Newswire (US) • 05/02/2024 08:01:00 PM
- AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024 • PR Newswire (US) • 05/01/2024 11:00:00 AM
- AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS • PR Newswire (US) • 04/29/2024 08:00:00 PM
- AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY • PR Newswire (US) • 04/26/2024 01:00:00 PM
- AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024 • PR Newswire (US) • 04/16/2024 09:26:00 PM
- AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024 • PR Newswire (US) • 03/09/2024 05:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:34:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:32:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:31:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:29:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:27:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:26:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:25:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:24:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:23:11 PM
- AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND • PR Newswire (US) • 03/06/2024 09:00:00 PM
- AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE • PR Newswire (US) • 02/29/2024 09:00:00 PM
- AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO • PR Newswire (US) • 02/26/2024 02:00:00 PM
- AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE • PR Newswire (US) • 02/19/2024 09:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/14/2024 09:23:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 12:50:46 AM
- AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE • PR Newswire (US) • 02/09/2024 09:00:00 PM
- Moody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market Updates • IH Market News • 02/07/2024 10:49:44 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM